1. Home
  2. CRMD vs ARQQ Comparison

CRMD vs ARQQ Comparison

Compare CRMD & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • ARQQ
  • Stock Information
  • Founded
  • CRMD 2006
  • ARQQ 2017
  • Country
  • CRMD United States
  • ARQQ United Kingdom
  • Employees
  • CRMD N/A
  • ARQQ 82
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • ARQQ Computer Software: Prepackaged Software
  • Sector
  • CRMD Health Care
  • ARQQ Technology
  • Exchange
  • CRMD Nasdaq
  • ARQQ Nasdaq
  • Market Cap
  • CRMD 865.2M
  • ARQQ 742.0M
  • IPO Year
  • CRMD 2010
  • ARQQ N/A
  • Fundamental
  • Price
  • CRMD $10.59
  • ARQQ $54.66
  • Analyst Decision
  • CRMD Strong Buy
  • ARQQ Strong Buy
  • Analyst Count
  • CRMD 8
  • ARQQ 1
  • Target Price
  • CRMD $17.57
  • ARQQ $60.00
  • AVG Volume (30 Days)
  • CRMD 2.6M
  • ARQQ 870.0K
  • Earning Date
  • CRMD 10-29-2025
  • ARQQ 05-22-2025
  • Dividend Yield
  • CRMD N/A
  • ARQQ N/A
  • EPS Growth
  • CRMD N/A
  • ARQQ N/A
  • EPS
  • CRMD 0.79
  • ARQQ 0.48
  • Revenue
  • CRMD $121,484,498.00
  • ARQQ $241,000.00
  • Revenue This Year
  • CRMD $480.51
  • ARQQ $284.30
  • Revenue Next Year
  • CRMD $59.81
  • ARQQ $415.45
  • P/E Ratio
  • CRMD $13.37
  • ARQQ $120.30
  • Revenue Growth
  • CRMD 14970.29
  • ARQQ N/A
  • 52 Week Low
  • CRMD $5.60
  • ARQQ $3.97
  • 52 Week High
  • CRMD $17.43
  • ARQQ $62.00
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 38.35
  • ARQQ 65.00
  • Support Level
  • CRMD $10.39
  • ARQQ $48.00
  • Resistance Level
  • CRMD $11.71
  • ARQQ $58.73
  • Average True Range (ATR)
  • CRMD 0.44
  • ARQQ 5.82
  • MACD
  • CRMD -0.04
  • ARQQ 1.06
  • Stochastic Oscillator
  • CRMD 12.34
  • ARQQ 75.95

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

Share on Social Networks: